Introduction Delivering sufficient therapeutics at the target site without off-target effects is a
major goal of drug delivery technology innovation. Among the established methods …

Nanomedicine in oncology has not had the success in clinical impact that was anticipated in
the early stages of the field's development. Ideally, nanomedicines selectively accumulate in …

Various X-ray imaging technologies like computed tomography (CT) and digital subtraction
angiography (DSA) are widely used in transcatheter arterial embolization (TAE) therapy for …

This study explores the challenges associated with nanoparticle-based drug delivery to the
tumor parenchyma, focusing on the widely utilized enhanced permeability and retention …

Prostate cancer (PCa) is the most common noncutaneous malignancy in men. Until recent
years, accurate imaging of men with newly diagnosed PCa, or recurrent or low-volume …

Purpose Contrast‐enhanced ultrasound (CEUS) by injection of microbubbles (MBs) has
shown promise as a cost‐effective imaging modality for prostate cancer (PCa) detection …

Nanobubbles (NBs;~ 100–500 nm diameter) are preclinical ultrasound (US) contrast agents
that expand applications of contrast enhanced US (CEUS). Due to their sub-micron size …

Contrast‐enhanced ultrasound is currently used worldwide with clinical indications in
cardiology and radiology, and it continues to evolve and develop through innovative …

Interfacial self‐assembly describes the directed organization of molecules and colloids at
phase boundaries. Believed to be fundamental to the inception of primordial life, interfacial …

Controlled drug delivery technology has matured for more than 70 years, starting from a
twice-a-day oral formulation to 6 month long-acting injectable formulations. Further …